The IXP Lifesciences Catalyst Fund has a greenshoe option of Rs 100 crore with an investment horizon of 3-5 years targeting ...

This new approach, powered by a specialised protein large language model, predicts the most effective protein variants while ...

Goldman Sachs made a significant adjustment to its stance on Regenxbio Inc . (NASDAQ:RGNX), downgrading the stock from "Buy" to "Neutral" and reducing the price target dramatically to $14.00 from the ...

The portfolio will comprise 20-25 B2B startups spanning Pre-seed to Series A stages, addressing innovation gaps in areas such as pharmaceuticals, biotechnology, medical technology, specialty chemicals ...

In December 2023, Infinitus and the two collaborating institutions submitted an application for the NationalKey R&D Program ...

Calling natural medicines as the solution to global health challenges, Rajasthan Assembly Speaker Vasudev Devnani called for the need for coordination between ancient and modern medical systems. He ...

A team of scientists from the Institute of Bio- and Geosciences–Biotechnology at Forschungszentrum Jülich worked together with the company Novonesis to develop a bacterium that "eats" individual ...

Application segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 8%. The AISS (Clinical) Application ...

From left: Dorah Momanyi, the CEO of iPoP Africa and a beneficiary of BioInnovate Africa, with innovations of popped grain ...

Budget emphasizes self-reliance in pulses, with a Rs 1,000 crore investment in hybrid technology and climate-resilient crops.